Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 September 2021 | Story Rulanzen Martin

As in previous years, the Department of South African Sign Language and Deaf Studies (SASL) – a pioneering force within deaf studies – will embark on a broader campaign to create much-needed awareness of the deaf. 

This year’s #UFSDeafAwarenesscampaign aims to inform and contribute to an inclusive society, not only among the UFS community, but also among the public. The department, together with the Centre for Universal Access and Disability Support, provides exceptional support to the 16 deaf and hard of hearing students at the UFS. 

Jani de Lange, Lecturer in Deaf Studies at the UFS, says the deaf forms part of the diverse South African community – “however, there are still many misconceptions about the deaf world. Therefore, deaf awareness plays an important role in facilitating a bridge between hearing and deaf people”.  

Awareness, duty, and social responsibility collide 

Many of the staff in the department considers themselves part of the deaf community. “They play a major role in educating others through our academic programmes, as well as continuous workshops and short learning programmes,” says De Lange. She continues, saying that by celebrating Deaf Awareness Month, “we are reminded of our role and responsibility towards the deaf.” 

The department also has a long-standing relationship with Mimosa Mall in Bloemfontein, with conversational students displaying their final group projects in the centre of the shopping mall.  Mimosa is also a partner in school-based projects, such as the Bartimea School for the Deaf and Blind in Thaba Nchu. “Every year, the department, together with our student association, Signals, and all interested Sign Language students, visits Bartimea, where we host a variety of activities with the children and also help the school with small maintenance projects. In 2019 – the last time we were able to visit the school – we repainted parts of the Foundation Phase’s playground,” De Lange says.

“We hope that the public will take the time to read about deafness, Sign Language, and the deaf community to understand the exciting traditions of the culture.”  The end goal is to encourage a greater understanding that ‘you do not need hearing to listen’

Getting the community involved 

To get people involved in the campaign, the department invites UFS staff to participate in a competition where they can learn how to introduce themselves in SASL. The department is also planning an informal training session for staff and students on 7 September 2021. 


The Department of SASL and Deaf Studies also presents a FREE Introduction to SASL short learning programme. 

  Click here for more information 


 #UFSDeafAwarenessMonth #DeafAwareness #DeafCommunity


                     


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept